Intranasal Midazolam Dosing for a 10 kg Child with Seizure
For a 10 kg child experiencing a seizure, administer intranasal midazolam 0.2 mg/kg (2 mg total), which can be repeated every 10-15 minutes if seizures continue, with a maximum single dose of 6 mg. 1
Specific Dosing Protocol
Initial Dose
- 0.2 mg/kg intranasally = 2 mg for this 10 kg child
- Divide equally between both nostrils
- Maximum single dose: 6 mg 1
Repeat Dosing
- May repeat every 10-15 minutes if seizures persist 1
- Monitor closely for respiratory depression between doses
Administration Technique
The evidence supports two practical methods:
- Preferred: Use an atomizer device for optimal mucosal absorption
- Alternative: Direct instillation from plastic ampoule or syringe is acceptable when atomizers are unavailable 2, 3
Recent Brazilian data demonstrates that rapid nasal instillation using only a syringe achieves comparable plasma midazolam concentrations (148.8 ng/mL vs 133.3 ng/mL, p=0.414) to atomizer delivery 2. This validates common emergency practice when specialized devices aren't immediately available.
Clinical Context and Comparative Effectiveness
Route Comparison
While the American Academy of Pediatrics guidelines list IM midazolam as the primary non-IV route for seizures 1, intranasal administration offers practical advantages in the acute setting:
- Faster administration: No need for IV access or IM injection positioning
- More dignified: Particularly important in community/home settings 3
- Effective: 89% seizure control rate in community settings 3
However, recent EMS data suggests intranasal midazolam may have higher odds of requiring additional benzodiazepine doses (OR=1.39,95% CI 1.10-1.76) compared to IM administration 4. This finding warrants close monitoring and readiness to provide rescue dosing.
Timing Considerations
Peak plasma concentrations occur approximately 10 minutes after intranasal administration 2. Wait this full interval before determining if repeat dosing is needed, as premature re-dosing increases respiratory depression risk without improving seizure control.
Critical Safety Monitoring
Respiratory Precautions
Prepare for respiratory support before administering any benzodiazepine 1:
- Monitor oxygen saturation continuously
- Have bag-valve-mask readily available
- Risk increases with:
- Rapid administration
- Concomitant sedative medications
- Age <6 months (though this patient is likely older given 10 kg weight)
Common Pitfall
Do not delay benzodiazepine administration to obtain blood glucose testing unless hypoglycemia is strongly suspected clinically. Only 61% of California EMS agencies require glucose testing before benzodiazepine administration for adults, and 76% for pediatrics 5, reflecting ongoing debate about this requirement potentially delaying definitive seizure treatment.
Escalation Pathway
If seizures persist after 2 doses of intranasal midazolam:
- Establish IV/IO access if not already obtained
- Consider alternative benzodiazepine: IV lorazepam 0.05-0.1 mg/kg (maximum 4 mg) is typically preferred for IV status epilepticus treatment 1
- Prepare for second-line agents: Phenytoin, fosphenytoin, or levetiracetam
- Early midazolam infusion consideration: If seizures continue, low-dose continuous midazolam infusion (<0.2 mg/kg/hr) initiated within 15 minutes of seizure onset shows superior outcomes compared to delayed initiation 6, 7
Alternative Routes for This Patient
If intranasal route is not feasible:
IM midazolam: 0.2 mg/kg = 2 mg (same dose as intranasal) 1
IV midazolam (if access available): 0.05-0.1 mg/kg = 0.5-1 mg for this patient 8
- Administer over 2-3 minutes
- Takes longer to establish access (median 13.1 minutes in EMS data) 4
Avoid rectal diazepam as first-line when intranasal or IM midazolam is available—caregivers consistently report intranasal administration as easier and more dignified 3.